Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Whiteside

Showing results (1-10 of 346) with videos related to

Pageof 35
Sort By:
Cancer Investigation|January 1, 1990
The natural killer (NK) cell and synergistic antitumor effects of interferon-gamma and interleukin-2T L Whiteside
Clinical and Diagnostic Laboratory Immunology|May 1, 1994
Cytokines and cytokine measurements in a clinical laboratoryT L Whiteside
Clinical and Experimental Immunology|April 4, 2017
Exosomes carrying immunoinhibitory proteins and their role in cancerT L Whiteside
In Vivo (Athens, Greece)|November 1, 1991
Cancer therapy with tumor-infiltrating lymphocytes: evaluation of potential and limitationsT L Whiteside
Immunology Series|January 1, 1994
Tumor-infiltrating lymphocytes in human solid tumorsT L Whiteside
Cancer Research|December 1, 1993
Correspondence re: J. P. Alexander et al., T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res., 53: 1380-1387, 1993T L Whiteside
Immunological Investigations|June 15, 2000
Immunologic monitoring of clinical trials in patients with cancer: technology versus common senseT L Whiteside
Immunology Series|January 1, 1994
Tumor microenvironment and immune effector cells. IntroductionT L Whiteside
The American Journal of Pathology|January 1, 1977
Reactivity of anti-human brain serum with human lymphocytesT L Whiteside
British Journal of Cancer|February 11, 2005
Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system?T L Whiteside
Pageof 35

Showing results (1-10 of 346) with videos related to

Sort By:
Pageof 35
Cancer Investigation|January 1, 1990
The natural killer (NK) cell and synergistic antitumor effects of interferon-gamma and interleukin-2T L Whiteside
Clinical and Diagnostic Laboratory Immunology|May 1, 1994
Cytokines and cytokine measurements in a clinical laboratoryT L Whiteside
Clinical and Experimental Immunology|April 4, 2017
Exosomes carrying immunoinhibitory proteins and their role in cancerT L Whiteside
In Vivo (Athens, Greece)|November 1, 1991
Cancer therapy with tumor-infiltrating lymphocytes: evaluation of potential and limitationsT L Whiteside
Immunology Series|January 1, 1994
Tumor-infiltrating lymphocytes in human solid tumorsT L Whiteside
Cancer Research|December 1, 1993
Correspondence re: J. P. Alexander et al., T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res., 53: 1380-1387, 1993T L Whiteside
Immunological Investigations|June 15, 2000
Immunologic monitoring of clinical trials in patients with cancer: technology versus common senseT L Whiteside
Immunology Series|January 1, 1994
Tumor microenvironment and immune effector cells. IntroductionT L Whiteside
The American Journal of Pathology|January 1, 1977
Reactivity of anti-human brain serum with human lymphocytesT L Whiteside
British Journal of Cancer|February 11, 2005
Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system?T L Whiteside
Pageof 35